| 000 | 01618 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515222243.0 | ||
| 264 | 0 | _c20110411 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-010-1335-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColombo, Valentina | |
| 245 | 0 | 0 |
_aChemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cFeb 2011 |
||
| 300 |
_a369-79 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDoxorubicin _xmetabolism |
| 650 | 0 | 4 | _aDrug Antagonism |
| 650 | 0 | 4 | _aDrug Resistance, Multiple |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPaclitaxel _xmetabolism |
| 650 | 0 | 4 |
_aSilymarin _xpharmacology |
| 700 | 1 | _aLupi, Monica | |
| 700 | 1 | _aFalcetta, Francesca | |
| 700 | 1 | _aForestieri, Daniele | |
| 700 | 1 | _aD'Incalci, Maurizio | |
| 700 | 1 | _aUbezio, Paolo | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 67 _gno. 2 _gp. 369-79 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-010-1335-8 _zAvailable from publisher's website |
| 999 |
_c19788457 _d19788457 |
||